---
title: "Tolvaptan - Polycystic Kidney, Autosomal Dominant"
sidebar: mydoc_sidebar
permalink: db06212-mesh-d016891-1.html
toc: false 
---


Path ID: `DB06212_MESH_D016891_1`
{% include image.html url="images/db06212-mesh-d016891-1.png" file="db06212-mesh-d016891-1.png" alt="db06212-mesh-d016891-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C116664">MESH:C116664 </a> | tolvaptan | Drug |
| <a href="https://identifiers.org/UniProt:P30518">UniProt:P30518 </a> | Vasopressin V2 receptor | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-418555">reactome:R-HSA-418555 </a> | G alpha (s) signalling events | Pathway |
| <a href="https://identifiers.org/CHEBI:17489">CHEBI:17489 </a> | 3,5-cyclic AMP | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0000107">HP:0000107 </a> | Renal cyst | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0008283">GO:0008283 </a> | cell population proliferation | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D016891">MESH:D016891 </a> | Polycystic Kidney, Autosomal Dominant | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tolvaptan | NEGATIVELY REGULATES | Vasopressin V2 Receptor |
| Vasopressin V2 Receptor | PARTICIPATES IN | G Alpha (S) Signalling Events |
| G Alpha (S) Signalling Events | INCREASES ABUNDANCE OF | 3,5-Cyclic Amp |
| 3,5-Cyclic Amp | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| 3,5-Cyclic Amp | POSITIVELY CORRELATED WITH | Renal Cyst |
| Renal Cyst | MANIFESTATION OF | Polycystic Kidney, Autosomal Dominant |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Polycystic Kidney, Autosomal Dominant |
|---------|-----------|---------|

Comment: This disease is also known as Polycystic kidney disease adult type as per the original file. Tolvaptan is also known as aquaretic (https://en.wikipedia.org/wiki/Aquaretic). Note that hyponatremia corresponds to the state where water content is relatively large for the sodium content available (https://pubmed.ncbi.nlm.nih.gov/19322975/), which is possibly due to increased water reabsorption.

Reference: 
  - [https://go.drugbank.com/drugs/DB06212#mechanism-of-action](https://go.drugbank.com/drugs/DB06212#mechanism-of-action)
  - [https://pubmed.ncbi.nlm.nih.gov/20868352/](https://pubmed.ncbi.nlm.nih.gov/20868352/)
  - [https://en.wikipedia.org/wiki/Autosomal_dominant_polycystic_kidney_disease#Aquaretic_medication](https://en.wikipedia.org/wiki/Autosomal_dominant_polycystic_kidney_disease#Aquaretic_medication)
  - [https://en.wikipedia.org/wiki/Vasopressin_receptor_antagonist#Polycystic_kidney_disease](https://en.wikipedia.org/wiki/Vasopressin_receptor_antagonist#Polycystic_kidney_disease)
